The reciprocal interplay between TNFα and the circadian clock impacts on cell proliferation and migration in Hodgkin lymphoma cells

Abreu, Mónica; Basti, Alireza; Genov, Nikolai; Mazzoccoli, Gianluigi; Relógio, Angela

doi:10.1038/s41598-018-29847-z

Download PDF

Article
Open access
Published: 31 July 2018

The reciprocal interplay between TNFα and the circadian clock impacts on cell proliferation and migration in Hodgkin lymphoma cells

Scientific Reports volume 8, Article number: 11474 (2018) Cite this article

3192 Accesses
23 Citations
5 Altmetric
Metrics details

Subjects

Abstract

A bidirectional interaction between the circadian network and effector mechanisms of immunity brings on a proper working of both systems. In the present study, we used Hodgkin lymphoma (HL) as an experimental model for a type of cancer involving cells of the immune system. We identified this cancer type among haematological malignancies has having a strong differential expression of core-clock elements. Taking advantage of bioinformatics analyses and experimental procedures carried out in III- and IV-stage HL cells, and lymphoblastoid B cells, we explored this interplay and bear out diverse interacting partners of both systems. In particular, we assembled a wide-ranging network of clock-immune-related genes and pinpointed TNF as a crucial intermediary player. A robust circadian clock hallmarked III-stage lymphoma cells, differently from IV-stage HL cells, which do not harbour a properly functioning clockwork. TNF and circadian gene modulation impacted on clock genes expression and triggered phenotypic changes in lymphoma cells, suggesting a crucial involvement of core-clock elements and TNF in the physiopathological mechanisms hastening malignancy. Our results move forward our understanding of the putative role of the core-clock and TNF in the pathobiology of Hodgkin lymphoma, and highlight their influence in cellular proliferation and migration in lymphatic cancers.

Circadian rhythm regulates the function of immune cells and participates in the development of tumors

Article Open access 27 April 2024

Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock

Article Open access 20 February 2024

Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity

Article Open access 20 January 2024

Introduction

Mammals, along with other species, have the ability to synchronize internal processes with changes in their environment. A circadian timing system regulates this synchrony and governs many aspects of cellular and behavioural physiology. These circadian rhythms allow organisms to anticipate daily light/dark cycles and are required to accommodate the 24 h pattern of rest and activity. The central pacemaker of the mammalian circadian system resides in the suprachiasmatic nucleus (SCN), and receives the light input from the external environment via the retinohypothalamic tract^1,2. The central clock transmits signals to multiple peripheral biological clocks present in all cells. These oscillations (with a period of ~24 h) are tissue-specific and recent studies with mice revealed that about 50% of all genes show circadian expression³. At the molecular level, the core-clock network (CCN) consists of a set of 14 genes that form auto-regulatory positive and negative transcription-translation feedback loops⁴. These genes encode for members of PER (Period - Per1, Per2, Per3), CRY (Cryptochrome - Cry1, Cry2), BMAL (brain and muscle ARNT-like protein – Bmal1, Bmal2), CLOCK (NPAS2 in neuronal tissue) and the nuclear receptors gene and protein families ROR (Rora, Rorb, Rorc) and REV-ERB nuclear orphan receptor (Rev-erbα, Rev-erbβ)⁵. The heterodimerization of CLOCK/BMAL1 triggers its nuclear translocation and initiates the transcription of the feedback loops. In the first loop, the CLOCK/BMAL1 complex binds to E-box sequences in the promoter regions of Per and Cry. The PER/CRY heterodimer translocates to the nucleus and interacts with CLOCK/BMAL1 to inhibit transcription. The second loop regulates the expression of Bmal1 by antagonistic effects of REV-ERB and ROR which compete for the ROR elements (RORE) in the Bmal1 promoter. While RORs activate the expression of Bmal1, REV-ERBs repress it^6,7.

Several biological processes are known to be under circadian regulation. These include the cell division cycle and DNA repair, RNA processing and transport, cellular metabolism, and the immune system functioning^{4,8,9,10,11,12,13,14}. Notably, several key parameters of the immune system in the blood show circadian rhythms, which include the number of circulating hematopoietic and immunocompetent cells, as well as hormones, monoamines and cytokines. In fact, the communication between the circadian clock and the immune system appears to be bidirectional. The circadian clock influences elements of the immune system in its two branches: the innate branch (e.g. rhythmic cytokine expression and rhythmic monocyte and macrophage functions); and the adaptive branch (e.g. rhythmic T- and B-lymphocyte expression and count) of the immune system and is involved in immune disease models^15,16,17,18. Interestingly, recent data show that the molecular clock controls metabolic pathways including immunometabolism and that the immune response (e.g. via TNF) could alter clock rhythmicity^19,20,21.

Disruptions in the circadian clock are known to be associated with several types of diseases. In humans, several studies confirmed that circadian desynchronization in respect to the environment correlates with higher incidence of several types of cancer. These include non-Hodgkin lymphoma, breast, endometrial, prostate and colon cancers^{8,22,23,24,25,26}. Furthermore, published data show that systemic inflammatory diseases are capable of altering the rhythmicity of several intrinsic signals. For example, effector cells in inflammatory reactions such as monocytes and neutrophils contain transforming growth factor (TGF-alpha) and release it upon activation²⁷. TGF-alpha is rhythmically expressed in the mouse SCN, where it negatively impacts on locomotion control acting through the epidermal growth factor (EGF) receptor²⁸. Moreover, the diurnal rhythms of leptin and cortisol secretion were lost in patients with acute sepsis²⁹. Increasing evidence point to TNF (tumour necrosis factor) as a putative bridging element in the CCN/immune system complex. TNF is a multifunctional pro-inflammatory cytokine that belongs to the tumour necrosis factor superfamily and acts as a tumour repressor. Published data have shown the existence of circadian rhythms of TNF secretion in spleen cells stimulated with bacterial endotoxin and a loss of LPS-induced phase-delays of locomotor activity rhythms in Tnfr1-defective mice³⁰. In particular, the expression of Per1 was shown to be suppressed by TNFα in the human pancreatic cancer cell line MIA-PaCa2³¹. These findings illustrate the significant regulatory role of the CCN on the immune response and support the further development of new therapeutic approaches, entailing chronotherapy and other time-dependent intervention strategies. Despite the increasing relevance of the biological clock in cancer onset and progression, the role of key immune elements, such as TNF, in mediating clock dysregulation in lymphatic cancers remains elusive.

Here, we used Hodgkin lymphoma (HL) cells as a lymphatic cancer cell model, to explore the effects of clock dysregulation in an immune-related context, though the chosen experimental system cannot be generalized to infer circadian clock functionality in HL or in other haematological neoplastic diseases. Considering that HL is a type of cancer involving cells of the immune system (lymphocytes), as a first step we generated a comprehensive circadian clock/immune system network of genes that pointed to TNF as a major networking partner. To further investigate the interplay between lymphoid malignancies and the circadian clock, in our disease model, we knocked-down (KD) several core-clock genes, including Bmal1, Per2 and Rev-erbα and analysed the effects in terms of changes in gene expression and cell phenotype (cell cycle phase, proliferation, apoptosis and migration).

Additionally, in our lymphatic cancer model, we investigated the role of TNF as a potential interacting partner between mutated pathways and the circadian clock. We stimulated WT and KD cells with TNF, as well as generated Tnf KD cell lines and analysed the effects on the clock phenotype and the cell cycle. Our findings from a combined experimental-bioinformatics approach suggest that in our model of lymphatic cancer the circadian clock impacts on the malignant phenotype and TNF acts as a major interacting partner for the circadian clock affecting key cellular functions.

Results

Immuno-clock network and clock signature in Hodgkin lymphoma

The circadian clock regulates several behavioural and physiological processes in mammals among which the immune response³². We used a previously generated network of circadian-regulated genes (NCRG)⁴ as the starting point for the construction of a comprehensive network of elements (genes, proteins, and protein complexes) which couple the core-clock to the immune system. The NCRG was derived from an extended core-clock network (ECCN) which represents a regulatory network containing elements that have direct interactions with the core-clock. Based on high-throughput gene co-expression data analysis and text-mining tools we further extended the ECCN network to build the NCRG, further developed in this work. A subsequent enrichment analysis for immune-related terms resulted in a selection of 16 genes from the ECCN and additional 39 genes from the NCRG. The selected genes were enriched in GO terms and/or KEGG immune-related pathways. We carried out a manual curation of published data on chrono-immunology, to complement the bioinformatics approach described above, which resulted in an additional list of 35 genes involved in immune function and response, and shown to be regulated by (or to regulate) the circadian clock. The newly generated regulatory network represents an up-to-date comprehensive bidirectional communication between the circadian clock and the immune system (Fig. 1, and Table S1).

The existence of a bidirectional communication between both systems, raises the interesting question regarding the putative role of this interplay in cancer. We aimed to choose an experimental cancer model of the immune system with differential expression of circadian clock elements. For this, we used high-throughput data from the Cancer Cell Line Encyclopaedia (CCLE)³³ and analysed the expression of core-clock elements.

We selected expression data from 172 haematopoietic and lymphoid tissue cancer cell lines and compared the normalized expression data in a pair-wise manner, among the different cancer groups.

Subsequently, we carried out an analysis for enriched elements present in the pathway “Circadian rhythms related genes“ in the WikiPathway data base. This list was mostly enriched in comparisons between Hodgkin lymphoma (HL), a lymphoproliferative disease characterized by the presence of Hodgkin and Reed-Sternberg cells, and the other haematological cancers with 37 ± 4 (mean, SEM) differentially expressed genes within the defined pathway (Fig. S2A–D). This points to a severe dysregulation of circadian clock elements in HL, as compared to other tumours of the hematopoietic and immune system, which made this particular cancer type an interesting model system for our subsequent analysis.

The Hodgkin lymphoma cell line HD-MY-Z shows robust oscillations in gene expression

We choose the HL cell lines HD-MY-Z (HL stage III b) and L-1236 (HL stage IV) to model disease progression and a lymphoblastoid B-cell line (LCL-HO) (established by EBV transformation, considering the recognized pathogenetic role for EBV infection in HL). There are relevant clinical differences between the different stages in Hodgkin lymphoma (HL). In stage III HL, the disease involves lymph node areas on both sides of the diaphragm or lymph nodes above the diaphragm and in the spleen. In stage IV HL, the disease has spread widely into at least one organ outside of the lymph system. In the presence of additional symptoms e.g. loss of more than 10% of body weight, fever and/or drenching night sweats, the letter B is added to the stage³⁴.

The three cell types exhibit different oscillatory patterns of core-clock gene expression as depicted by non-invasive long-term bioluminescence recording and expression of the core-clock genes, Bmal1 and Per2 (Fig. 2E–G). LCL-HO (T = 29.33 ± 1.27 h; n = 3; mean and SEM) and L-1236 (T = 32.61 ± 2.35 h; n = 3; mean and SEM) showed weak oscillations for both genes with prolonged periods (representative results in Fig. 2E,G), thus suggesting a disruption in the circadian clock machinery in the mentioned cell lines. Furthermore, the antiphasic oscillation pattern between Bmal1 and Per2 is partially lost for these cell lines. In contrast, the HL cell line HD-MY-Z showed a strong circadian clock with robust (T = 23.51 ± 0.055 h; n = 3; mean and SEM; representative results in Fig. 2F) and antiphasic oscillations of Bmal1 and Per2. We subsequently focused on HD-MY-Z cells as a HL model and the EBV growth-transformed lymphoblastoid LCL-HO cell line as a model system of EBV latency and virus-driven B cell proliferation and tumorigenesis. In these cell lines, we further analysed the expression levels for Bmal1 and Per2 via RT-PCR in the course of 24 hours, and these were in agreement with the bioluminescence data (Fig. S1A,B).

To investigate the overall presence of circadian oscillating genes in the LCL-HO and the HL cell line HD-MY-Z, we carried out a genome wide time-course array analysis. Out of all genes, 55% (13825) were differentially expressed between both cell lines including a set of genes enriched for the TNF signalling pathway (P = 5.18E-10) (Fig. S2A–C). Among those, 7402 genes (29%) were downregulated in the HL cell line and 6495 (26%) were upregulated, as compared to the lymphoblastoid B-cells. Our enrichment analysis indicated the predominance of cancer-related pathways within the set of upregulated genes, and immune-related pathways for the set of downregulated genes. Interestingly, the circadian rhythm pathway is enriched in the HL cell line HD-MY-Z, in the set of upregulated genes (P = 0.0117) (Fig. S2D,E). The strong upregulation of the circadian rhythm pathway prompt us to analyse the expression levels of the CCN genes for both cell lines in more detail (Fig. 3A). In particular, the expression levels of Cry1 and Npas2 were strikingly different between the two cell lines (Fig. S1C). This finding was also confirmed by RT-qPCR, which showed more than a 2-fold increase in the expression of Cry1 and Npas2 in the HL cell line HD-MY-Z as compared to the lymphoblastoid B-cells LCL-HO (Fig. S1D). Both Cry1 and Npas2 (a paralog of CLOCK) belong to core-clock components and regulate the negative and positive feedback loops, respectively. They are involved in DNA damage response and cell cycle, and are important for maintaining the correct circadian rhythm of the cells. Next, we searched for commonly/differentially oscillating genes in both cell lines. As expected, the HL cell line HD-MY-Z, which showed a robust circadian clock, had a higher number of oscillating genes than the lymphoblastoid B- cell line LCL-HO (7462 and 1925 oscillating genes respectively, Fig. 3B). Notably, there were 746 genes oscillating in both cell lines. Both subsets of oscillating genes showed similar enriched pathways, with a predominance of cancer-related terms (Fig. 3C,D). Tnf oscillated with significant values in both cell lines (LCL-HO, P = 0.003; HD-MY-Z, P = 0.01) as depicted in Fig. 3E and it was also differentially expressed in both cells. TNF signalling was one of the most enriched pathways among the downregulated genes in HD-MY-Z (Fig. S2D). This corroborated a role for TNF as a modulator of the circadian clock in our cellular model of a cancer type involving cells of the immune system.

TNF stimulation alters CCN gene expression and cell cycle phase

TNF is a potent pro-inflammatory cytokine responsible for the regulation of immune cells. This cytokine was also reported as a regulator of genes of the CCN^35,36. To gain a deeper understanding of the role of TNF as an elicitor of the core-clock, we stimulated the HL cell lines HD-MY-Z and L-1236 (HL, stage-IV), which showed weaker oscillations compared to the HD-MY-Z cell line (HL stage-III, Fig. 2F,G), with TNF for three days and measured gene expression levels of the core-clock genes Bmal1, Per2, Cry1, Cry2, Rev-erbα, as well as Tnf (Fig. 4A). The stimulations were carried out at a specific time point, but the cells remained in the presence of the stimulating agent during the three days (Materials and Methods) so we no longer had a single time point effect, but a constant effect, as compared to the non-stimulated condition. Our results indicated a general increase in the expression of all core-clock genes in the HL cell line HD-MY-Z upon TNF stimulation, with Per2, Cry1 and Cry2 showing significant changes (P < 0.01, P < 0.001 and P < 0.05 respectively). In contrast, in the HL cell line L-1236 after a three-day stimulation with TNF there were no changes observed in the mRNA expression levels of the mentioned genes. Additionally, we carried out stimulations with dexamethasone and forskolin, to introduce clock perturbations. Dexamethasone is a known potent anti-inflammatory agent used to treat inflammatory and autoimmune diseases³⁷. It is also used in many circadian studies to synchronize cells in culture³⁸. Like dexamethasone, forskolin is also used to synchronize the cellular clock³⁸ and in addition it has a known inhibitory effect on Tnf³⁹. Here we stimulated the two HL cell lines, and the lymphoblastoid B-cell LCL-HO with dexamethasone and forskolin for three consecutive days, and evaluated the resulting phenotype in the clock machinery, as well as in Tnf (Figs 4A, and S3A–E, S4A–E). Furthermore, we additionally examined the impact of TNF stimulation on TNF and IL-6 secretion in the three cell lines (Figs 4B, S5). Interleukin-6 (IL-6) is secreted by HL cells, throws in the immunoreactive phenotype and plays a significant pathobiological role in this lymphatic cancer⁴⁰. As expected, the levels of extracellular TNF increased in all cell lines upon stimulation. Interestingly, the two cell lines showing weaker oscillations (lymphoblastoid B-cell LCL-HO and the HL cell line L-1236, Fig. S5), had higher levels of both TNF and IL-6 in the supernatant as compared to the HL cell line HD-MY-Z. Next, we analysed the possible impact of TNF stimulation on the cell cycle in the three cell lines (Figs 4C, and S3D, S4E) and observed a significant change for the HL cell line HD-MY-Z, which resulted in an increased ratio of cells in the S phase, suggesting a proliferative role of TNF in this cell line.

TNF downregulation influences the expression of core-clock elements

We performed shRNA KD in CCN elements and in Tnf to evaluate the output in terms of gene expression, cell proliferation, extracellular concentration of TNF, cell cycle, apoptosis and migration. Upon shBmal1 KD, the HL cell line HD-MY-Z showed a significant increase in the expression of Per2 and Cry2 and a decrease in Rev-erbα, as well as a decrease in Tnf expression (Fig. 4D). Additionally, shTnf caused alterations in gene expression of Per2 and Rev-erbα, increasing and decreasing their expression, respectively, in the HL cell line HD-MY-Z, while the KD of Rev-erbα led to an increase in the expression of Bmal1 and Per2 (Figs 4D and S6). Per2 and Rev-erbα silencing exhibit different and specific effects on the expression of core-clock genes in the three cell lines used in this work. In LCL-HO, only Rev-erbα downregulation caused significant alterations in Cry1 and Cry2 increasing their expression, which is in agreement with the known negative regulation of Rev-erbα on Cry expression. In the HL cell lines, we observed an increase in Per2 and Bmal1 expression after Rev-erbα downregulation. Additionally, the KD of Per2 led to an increase in Tnf expression, in the HL cell line HD-MY-Z. In the HL L-1236 cell line however, we could not detect significant changes in the expression of core-clock genes and Tnf both in shPer2 as in the shRev-erbα cell lines. For the HL cell line L-1236, we observed similar results for Rev-erbα gene expression in the shBmal1 cells, but the expression levels of Per2 and Cry2 remained unchanged. In the same cell line, the expression of Cry1 was significantly decreased (Fig. 4D). The KD of Bmal1 led to cell death in the LCL-HO cell line (Fig. S3E). Taken together, these results suggest a major role of TNF in the regulation of several key core-clock genes.

Effects of TNF stimulation on key cellular characteristics of the KD cell lines

Next, we aimed to explore the stimulatory effects of TNF in the expression of core-clock genes (Bmal1, Per2 and Rev-erbα), as well as in the expression of Tnf in the KD cell lines. The KD cells were stimulated for three days with 50 ng/mL of human recombinant TNF, 0.1 µM of dexamethasone or 25 µM of forskolin. The stimulation of the HL cell line HD-MY-Z with human recombinant TNF triggered an increase in gene expression of the evaluated genes in all the considered experimental conditions (Fig. 5A). When compared to the non-stimulated control (non-stimulated, empty vector), the main differences were found in Per2 expression for shBmal1 cells, Tnf expression in shPer2 cells and Bmal1 expression in shRev-erbα cells. Additionally, the downregulation of Tnf caused an increase in Per2 expression and a decrease in Rev-erbα expression. We observed an increase in the expression of Bmal1 and Per2 in shRev-erbα cells. We further observed an increase in the extracellular concentration of TNF for shPer2 and shRev-erbα cells, suggesting an inhibitory effect of Per2 and Rev-erbα on TNF secretion (Fig. 5B). Furthermore, given the known correlations between IL-6 and TNF expression and also the clock^41,42, we aimed to explore whether changes in the expression of TNF in different KD cell lines and after TNF stimulation impacts IL-6 expression (by measuring the IL-6 concentration in the supernatant). An increase of IL-6 concentration was also observed in LCL-HO shRev-erbα cell line (Fig. S3).

We further analysed the impact on the cell cycle caused by perturbations in the core-clock, as well as in Tnf and observed an increase in the percentage of cells in G1 phase and decrease in G2 phase of the cell cycle for the different knockdowns in the HL cell line HD-MY-Z (Fig. 5C). We did not observe a significant effect on the cell cycle in shTnf and shRev-erbα cells upon stimulation with TNF, as compared to the observations in the non-stimulated scenario, however, shBmal1 cells acquired a profile closer to the non-stimulated control and the shPer2 cells showed an increase in the G2 cell cycle phase. Despite the similar output in terms of Tnf inhibition, dexamethasone and forskolin did not have similar effects on gene expression of core-clock genes and cell cycle, in the HL cell line HD-MY-Z. Forskolin decreased the Per2 and Cry2 expression in the shBmal1 cells (Fig. 5A). In HD-MY-Z-shTnf cells, we observed a decrease in Per2 gene expression and an increase in Tnf, after forskolin treatment. Both dexamethasone and forskolin increased Per2 expression in HD-MY-Z-shPer2-cells, however, forskolin also showed an effect on Bmal1, increasing its expression. In shRev-erbα cells treated with forskolin there was a decrease in Per2 expression. Dexamethasone treatment led to an increase in G2 and decrease in G1 phases in the HL cell line HD-MY-Z as compared to non-stimulated cells, and increased G1 phase in shPer2 and shRev-erbα conditions (Fig. 5C). Similar to dexamethasone, forskolin also increased G2 and decreased G1 cell cycle phases as compared to non-stimulated cells, however these effects were more prominent. Cell cycle profiles of shTnf and shRev-erbα cells showed alterations after forskolin stimulation, which reverted the effects caused by the shRNA towards a profile similar to the non-stimulated cells (Fig. 5C). In shPer2 cells, forskolin caused an increase in G2 with a consequent decrease in G1, as compared to the non-treated HD-MY-Z-shPer2. Finally, we examined the impact of the different knockdowns on cell proliferation, for the HL cell line HD-MY-Z (Fig. 5D). Compared to the pLKO.1 (empty vector), shPer2 cells showed increased proliferation, whereas shBmal1 and shTnf dramatically reduced proliferation (Fig. 5D).

Dysregulation of the circadian clock impacts HL cell migration and apoptosis

We further analysed the influence of circadian clock dysregulation in the HL cell line HD-MY-Z regarding apoptosis and migration. Our data showed a remarkable decrease in apoptosis in shPer2 and shTnf HD-MY-Z-cells and an increase of apoptosis in the shRev-erbα cells (Fig. 5E). To investigate the role of TNF in apoptosis, we stimulated all KD cell lines with TNF and measured their apoptotic rate. Upon TNF stimulation, we observed a general increase in the apoptosis rate of shRev-erbα-, shTNF- and shBmal1-HD-MY-Z cells, corroborating a tumour suppressing role for TNF (Fig. 5F). Interestingly, shPer2 cells exhibited a greater decrease in apoptosis compared to the non-stimulating scenario (Fig. 5E,F). This points to an inhibitory effect of TNF on Per2 expression resulting in reduced apoptosis.

We additionaly explored the impact of the different perturbations in the migratory properties of the HL cell line. Cell migration was determined by measuring the wound confluence over 34 hours (Fig. 6A,B). Among all KD cell lines, shRev-erbα showed the highest migration activity when compared to the empty vector control cells, suggesting that suppression of Rev-erbα expression had a positive effect on the migration properties of the HL cell line HD-MY-Z. In contrast, shTnf and shBmal1 cell lines showed decreased migration when compared to the empty vector control cells. These results indicate that CCN genes, as well as TNF are involved in key cellular properties of HL cells, and their influence in cell proliferation and migration may play a role in HL progression.

Discussion

The circadian clock machinery generates rhythmic patterns in the expression of genes and proteins that allow physiological and cellular functions to be fine-tuned and coordinated in time. These are crucial for the timely segregation of incompatible cellular processes and for energy conservation purposes. This preserved rhythmicity characterizes also the function and components of the immune system, and ensures the conservation of body homeostasis and defence mechanism. Several studies point to a bidirectional crosstalk between the circadian pathway and the immune system, and characterize the effects of inflammation and cytokines on circadian rhythms^43,44.

In this study, we further investigated the extent of such a bidirectional communication in a lymphatic cancer and validated different interacting partners of both systems by generating a comprehensive network of clock-immune related genes (NCIRG) which highlighted a major potential bridging element, TNF. To examine this interplay, we first carried out an enrichment analyses for circadian rhythm related genes in different cancers and found Hodgkin lymphoma to have a significant differential expression for genes of the circadian rhythm pathway.

From the analysis of high-throughput time-course data for a stage-III HL cell line (HD-MY-Z) and by comparing these results with the lymphoblastoid-B cell line, LCL-HO, which exhibits weak oscillations in the expression of core-clock genes, we determined the number of oscillating genes in both cell lines and found a strong link between the oscillating genes and cancer-related pathways, in particular for the HL cell line HD-MY-Z. Since we identified more robust circadian oscillations and a larger number of oscillating genes in the HL cell line HD-MY-Z with respect to the LCL-HO cell line, we suggest that a properly functioning circadian clock machinery might be necessary for HD-MY-Z cell survival and malignant phenotype. Tnf is a well-known immune system gene. Its expression is controlled by the core-clock network via the D-box elements found in its promoter region⁴⁵. TNF and its receptors (TNFR1 and TNFR2) fulfil several functions, namely the crucial control of lymphocyte expansion and preservation of their structural integrity, and function as well as immunocompetent cells in the development of immune responses. TNF seems to act as a bridging element between the core-clock and the immune system, as also shown by our data. TNF modulates the immune system function through the down-regulation of T-cell receptor (TCR) signalling, calcium flux changes, p21, p23 and ZAP70 activation, and reduced NF-κB nuclear activation⁴¹. Conversely, the biological clock directly controls the production of important cytokines: in particular CRY1 and CRY2 suppress the expression of the genes encoding TNFα and IL-6, and REV-ERBα restrains the induction of IL-6. In turn, these cytokines impact the functioning of the biological clock⁴². IL-6 levels are augmented in patients with Hodgkin lymphoma and are correlated with a poor prognosis. Also in our study we measured an increase of IL-6 in the HL stage-IV cell line L-1236, as compared to the stage-III cell line HD-MY-Z. Furthermore, IL-6 and other cytokines are produced in HL by Reed-Sternberg cells or infiltrating reactive cells, comprising lymphocytes, plasma cells, eosinophils and histiocytes, and might contribute to the impairment of immune response and to leukocyte trafficking, preserving a supporting environment for RS cells survival. IL-6 acts in an autocrine or paracrine way supporting a tumour environment that allows for Reed-Sternberg cells survival and proliferation by hindering apoptosis and host anti-tumour defence, which is likely to trigger weight loss, night sweats, fever, and other paraneoplastic reported symptoms⁴⁶. The appropriate modulation of IL-6 dependent pathways may consent to expand the targeted approaches in HL therapy⁴⁷.

In our experiments, we inspected the oscillating pattern of Tnf expression in the HL cell line HD-MY-Z and the lymphoblastoid-B cells LCL-HO and investigated the role of TNF stimulation at the molecular and cellular levels in WT and knock-down variants of HD-MY-Z. Upon TNF stimulation, we observe a general increase in the expression levels of core-clock elements, among them Bmal1, Per2 and Rev-Erbα. This finding is consistent with previous studies in rheumatoid synovial cells³⁶ and in fibroblasts at early time points⁴⁸ which point to elevated expression of the mentioned genes upon TNF stimulation. Following gene knock-down, we measured gene-specific effects of TNF on the core-clock elements. In particular, Per2 expression appears to be negatively controlled by TNF. While the expression of Per2 was significantly increased in shTnf cells, Tnf expression was increased dramatically in shPer2 cells. This inhibition could be due to E-box-mediated interfering effects of TNF on Per2 transcription as previously reported⁴⁹. In patients with metastatic colorectal cancer statistically significant correlations were found between pre-treatment levels of cytokines, circadian patterns in wrist activity and serum cortisol and tumour-related symptoms. In particular, patients with reduced 24-hour rest/activity patterns quantified by actigraphy showed significantly higher serum levels of TGF-α, TNF-α and IL-6¹⁷. Similarly, in our study we observe higher levels of TNF-α for the two cell lines which have the less robust clock (LCL-HO and the HL cell line L-1236, Fig. S5) further strengthening the previously described correlation between the clock phenotype and alterations in immune elements, in a cancer context.

Our results further indicate a role for TNF as an enhancer of proliferation leading to an increased amount of cells in the S-phase in HD-MY-Z cells (Fig. 6C) which can be achieved via the activation of the NF-kB pathway. Interestingly, we did not find significant effects of TNF stimulation in the cell cycle for LCL-HO and L-1236 cell lines indicating its specific role in cell lines which are hallmarked by proper oscillations of clock genes. As such, the loss of a functional clock in the L-1236 seems to affect the feedback from the TNF to the core-clock clock (upon perturbation of TNF the expression levels of the clock genes is rather constant), and to result in a larger S-phase, as observed for these cells. Interestingly, in non-Hodgkin lymphoma patients circadian rhythms in S-G2-M cell cycle phases were shown in malignant lymph nodes of stage IIIB (p = 0.046 for 24-h cosine fit), but not stage IV (p = 0.560 for 24-h cosine fit) disease¹⁶. Even though this is a different model (non-Hodgkin lymphoma) as compared to the one used in our work (Hodgkin lymphoma), we observed as well a loss of robustness in circadian rhythms for the stage IV cell lines. This could indeed impact the cell cycle given the strong interconnection between the cell cycle and the circadian clock oscillators, as shown by our own work and others^14,50.

Altogether, our results obtained from KD cell lines, point to a role of TNF in regulating the cell cycle for HD-MY-Z KD cells, and its ability to restore altered cell cycle phases in KD cells. Our results from the proliferation analysis data identified Per2 as a potential proliferation inhibitor, while Bmal1 and Tnf acted as enhancers of cell proliferation in the HL cell line HD-MY-Z. This could result from the negative regulatory role of PER2 in the clock machinery and the positive effects of BMAL1 and TNF in enhancing the transcription of clock-controlled genes involved in proliferation. Importantly, Bmal1 and Per2 may impact cellular physiology in different ways. Either influencing the clock machinery and altering circadian rhythms, and/or by influencing the expression of genes that are direct targets of CLOCK/BMAL1 and/or of PER2. This could be a result of other potential, non-circadian, functions of Bmal1 and Per2. To differentiate between these two hypotheses and to better characterize the specific output results of Bmal1 and Per2 knock-down phenotypes further studies are necessary.

Cell apoptosis was dramatically influenced and decreased in shPer2 cells upon TNF stimulation (Fig. 6C), which can be correlated with the inhibitory effects of TNF on Per2. Since TNF represses Per2 expression, this could lead to a decreased expression of Bmal1 resulting in reduced CLOCK/BMAL1 levels and eventually derepression of c-Myc followed by reduced apoptosis, as previously reported⁵¹. The migratory properties of the HL HD-MY-Z KD cell lines reveals a role for Rev-Erbα as a motility suppressor. These findings corroborate the results of experiments performed in an acute myeloid leukaemia mouse model showing that leukaemia stem cells are dependent on a functioning biological clock. Derangement of the molecular clockwork induces weakened proliferation, superior myeloid differentiation, and leukaemia stem cells exhaustion, with resulting overall anti-leukemic effects⁵². It would be interesting in future work to validate our results in an in vivo model (mouse, humans). However, this goes beyond the scope of this study that we consider exploratory in this first phase.

The interplay between the circadian and the immune systems highlighted by our bioinformatics analyses and corroborated by our experimental procedures performed in lymphoma cells pinpointed a crucial role played by this bidirectional interaction in determining cancer cell phenotype. According to our results, a deregulated biological clock impacts on proliferation, migration and cell death in HL cell lines. Differently from what has been observed for solid cancers, a well-running molecular clockwork ticks in medium stage lymphoma cells and supports malignancy, whereas its perturbation hinders malignant phenotype maintenance and it seems to be altered in more advanced lymphoma stages. Hodgkin lymphoma, as well as other lymphoma types, is not representative of the whole immune system, considering the monoclonality hallmarking cancer beyond intratumour heterogeneity in comparison to the multiclonality of the majority of immune components, and the genomic and phenotypic alterations of a cancer respect to the normal tissue. As such, additional model systems such as T-cell lymphoma, leukaemia and multiple myeloma should be considered in future work, to further extend the findings here reported to cancers of the immune system. Key players in the aforementioned interplay could be represented by small molecules, in particular cytokines such as TNF and IL-6, whose secretion is circadian regulated, and which have been shown capable to impact the functioning of the biological clock. In our study we focused on TNF, a major inflammatory cytokine originally documented as capable to provoke, in experimental cancers, haemorrhagic necrosis, but subsequently found to paradoxical act as a tumour-promoter. Our results corroborate its role as a key intermediary of the circadian - immune network, impacting the expression of core-clock genes and inducing phenotypic changes in lymphoma cells. The findings of our experimental approach may also contribute to advance our knowledge of the physiopathological mechanisms bringing on malignancy in lymphoma cells with the aim to identify key molecules and valuable compounds for potential targeted therapeutic strategies. Even though we did not explore the usage of therapeutics associated to the circadian system⁵³ in this work, there are potential implications of our findings in the clinic which justify future work. Cell-autonomous molecular clockworks may play a significant role in lymphoid malignancies treatment impacting lymphatic cancer cells phenotype and in particular cell growth and proliferation, by driving oscillations of cell-cycle genes important for the G1-to-S transition. The cell division cycle is under circadian control and restoring clock function in lymphatic cancer cells harbouring a dysfunctional molecular clockwork could slow down their growth. In contrast, clock-interfering treatments such as inhibition of the cancer clock by shRNA-mediated knock-down, could significantly decrease proliferation and tumour growth in lymphatic cancer cells hallmarked by rhythmic clock gene expression. Characterization of the subjective patterns of oscillatory gene expression could orientate tailored therapy of lymphoma patients in the setting of personalized medicine. Furthermore, the investigation of the circadian control over the cell cycle through small molecules impacting the biological clock could lead to the modulation of lymphatic cancer cells proliferation and support anticancer effects of chemotherapy and surgical tumour resection.

Methods

Network of clock-immune related genes

The network construction involved two different approaches. In the first approach, an enrichment analysis of the previously published network - NCRG⁴ was carried out using DAVID Bioinformatics Resources 6.8⁵⁴. Genes containing immune-related associations were selected for the present network. Interactions from the previous network were maintained and are represented in grey. Text mining was performed with the Agilent Literature Search plugin for Cytoscape using the Pubmed database. The second approach involved manual curation of published experimental data. Positive and negative interactions are represented in green and red, respectively. Network visualization was generated using Cytoscape version 3.4⁵⁵. A list of new interactions can be found in Table S1.

Cancer Cell Line Encyclopaedia (CCLE) analysis

Cancer Cell Line Encyclopaedia (CCLE) contains expression data from 947 cancer cell lines performed using Affymetrix GeneChip Human Genome U133 Plus 2.0 Array. A total of 174 cell lines were included in the CCLE tumour type group 2 (haematopoietic) and grouped into 10 different groups: acute myeloid leukaemia (AML, n = 33), B cell acute lymphoblastic leukaemia (B-cell ALL, n = 12), chronic myeloid leukaemia (CML, n = 14), T-cell acute lymphoblastic leukaemia (T-cell ALL, n = 14), others_leukaemia (n = 5), Burkitt’s lymphoma (n = 10), diffuse large B cell lymphoma (DLBCL, n = 16), Hodgkin lymphoma (HL, n = 13), others_lymphoma (n = 28) and multiple myeloma (n = 27). Robust Multi-array Average (RMA) normalisation was performed by the Expression Console (EC (Affymetrix)) and Gene level differential expressed analysis were performed by Transcriptome Analysis Console v3.0 (TAC (Affymetrix)). One-Way Between-Subject ANOVA (unpaired) algorithm was used to detect differential expressed genes (filter criteria: Fold Change (linear) <−2 or >2 and ANOVA p-value (condition pair) <0.05). Heatmaps were generated using ComplexHeatmap software package⁵⁶ for statistical programing environment R. The number of differentially expressed genes in the “Circadian rhythm related genes” (WikiPathways⁵⁷) was manually counted.

Cell culture

HD-MY-Z (DSMZ – #ACC 346): established in 1991 from the pleural effusion (rich in Hodgkin/Reed-Sternberg cells) from a 29-year-old patient with nodular sclerosing Hodgkin lymphoma (stage IIIb) refractory to therapy. Semi-adherent spheroid to fusiform cells growing in clumps in mono- and multilayers. Doubling time: ca. 35 hours. L-1236 (DSMZ - #ACC 530): established from the peripheral blood of a 34-year-old man with Hodgkin lymphoma (mixed cellularity, stage IV, refractory, terminal, third relapse) in 1994. Semi-adherent spheroid to fusiform cells growing in clumps in mono- and multilayers. Doubling time: ca. 48 hours. LCL-HO (DSMZ – #ACC 185): B lymphoblastoid cell line, established by EBV transformation (Epstein-Barr virus). Lymphoblastoid-like cells growing in suspension singly or in clumps. Doubling time: ca. 30 hours.

HD-MY-Z, LCL-HO and L-1236 (Hodgkin lymphoma, stage IV, refractory, terminal, third relapse) cell lines were maintained in RPMI 1640 (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco). Stable-transduced cells were selected and maintained in medium containing 100 μg/mL hygromicin B (Gibco) for the Bmal1:luc hygromicin (BLH), 10 μg/mL of blasticidin S HCl (Gibco) for the Per2:luc blasticidin (PLB) and 10 μg/mL of puromycin for the shRNA KD of the clock genes and Tnf. For live-cell bioluminescence recording (evaluation/analysis/monitoring), cells were maintained in phenol red-free RPMI 1640 (Gibco) containing 10% foetal bovine serum, 1% penicillin-streptomycin and 0.1 mM D-Luciferin (PJK). For cell stimulation, cells were maintained for 3 days in medium (RPMI 1640 (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco)) with 50 ng/mL of human recombinant TNF (BioLegend), or 0.1 µM of Dexamethasone (Sigma-Aldrich) or 25 µM of Forskolin (Sigma-Aldrich) as previously described^{58,59,60,61,62}. Cell morphology and concentration were analysed in LUNA™ Automated Cell Counter (Logos Biosystems). All cells were incubated at 37 °C with 5% CO₂ atmosphere. All three cell lines express glucocorticoid, TNF and cathecolamine receptors as previously reported^63,64 and as also fund in our array data.

Lentivirus production

Lentiviral elements containing a BMAL1-promoter-driven luciferase (BLH), a PER2-promoter-driver luciferase (PLB), an empty vector (TRC Lentiviral pLKO.1 Empty Vector Control Dharmacon Inc., Lafayette, CO) or a shRNA KD (TRC Lentiviral Human ARNTL shRNA - Clone ID: TRCN0000019097; TRC Lentiviral Human TNF shRNA - Clone ID: TRCN0000003758; TRC Lentiviral Human PER2 shRNA - Clone ID: TRCN0000018541;TRC Lentiviral Human NR1D1 shRNA - Clone ID: TRCN0000022176 (Dharmacon Inc., Lafayette, CO)) were used in the present work. HEK293T (human, kidney, ATCC Number: CRL-11268) cells were seeded in 175 cm² culture flasks and co-transfected with 12.5 µg packaging plasmid psPAX, 7.5 µg envelope plasmid pMD2G and 17.5 µg BLH,PLB or shRNA KD expression plasmid using the CalPhos mammalian transfection kit (Clontech) according to the manufacturer’s instruction. To harvest the lentiviral particles, the supernatant was centrifuged at 4100 × g for 15 min to remove cell debris and passed through a 45 µm filter. Lentivirus were stored at −80 °C.

Transduction with lentiviral vectors

1 × 10⁶ cells were seeded in a 6-well plate with 1 mL of RPMI1640, 10% foetal bovine serum, 1% penicillin-streptomycin and 4 µg/mL Polybrene (Sigma). 1 mL of supernatant of the corresponding lentivirus were added to each well and plates were centrifuged for 90 min at 34 °C at 1000 g. Supernatant was discarded after 4 hours incubation at 37 °C with 5% CO₂ and 2 mL of fresh medium was added. Two days after, the medium was replaced by selection medium (supplemented with hygromicin S, basticidin S HCl or puromycin (according to the lentivirus construct used)) and incubated at 37 °C with 5% CO₂ atmosphere. Cells were maintained in selection medium for at least two weeks. For the shRNA KD, the KD efficiency was determined by gene expression analysis.

Synchronization and measurement of circadian rhythms

For bioluminescence measurement, 0.5–1 × 10⁶ cells were washed once with 1× PBS, plated in 35 mm dishes and synchronized by adding fresh phenol-red-free RPMI 1640 medium supplemented with 10% foetal bovine serum, 1% penicillin-streptomycin and 0.1 mM D-Luciferin. Bmal1-promoter-(BLH)-reporter or Per2-promoter-(PLB)-reporter activities were measured, using the LumiCycle instrument (Actimetrics). After bioluminescence recording for 5–7 days, phase, period and amplitude were analysed with the ChronoStar analysis software V3.0 using 24 h running average de-trended method and fitting cosines curves were calculated as output⁶⁵.

RNA isolation and cDNA synthesis

Cells were seeded in 35 mm dishes with a density of 5 × 10⁵ cells/dish and synchronized by fresh medium addition. Cells were collected every three hours, in triplicates and the pellets were stored at −80 °C. Total RNA was isolated using the RNeasy extraction kit (Qiagen), including DNase digestion, according to the manufacturer’s instructions. Cells were lysed with 350 µl RLT buffer and the lysate was homogenized. Total RNA concentration was determined using NanoDrop® ND-1000 UV-Vis Spectrophotometer and stored at −80 °C. 1 µg of total RNA was reverse-transcribed to cDNA with M-MLV reverse transcriptase (Invitrogen), random hexamers (Eurofins MWG Operon) and dNTPs Mix (Thermo Fisher).

Quantitative real-time PCR

For gene expression quantification, we used SYBR-Green (Bio-Rad Laboratories, Hercules, CA) based real-time PCR in 96-well plates and the human commercial primers from QuantiTect primer assays (Qiagen) for Gapdh (housekeeping gene), Bmal1, Per2, Tnf, Cry1, Cry2 and Rev-erbα. The reaction was performed in a real-time PCR Detection System (Bio-Rad). Each sample was measured in duplicates and the C_T values were determined by using the regression method. The expression levels were normalized to those of Gapdh (ΔCT) and calibrated to the mean expression value of each gene (time-course analysis) or in relation to the respective control. (ΔΔC_T). The relative quantification was performed using the 2^−ΔΔCT method.

Microarray analysis

Microarray analysis was performed in R version 3.4.2 using the oligo package. Multi-Array Average (RMA) pre-processing procedure was used to normalise expression levels of genes⁶⁶. HTA 2.0 were annotated by merging data with probeset annotations provided online (www.affymetrix.com). Heatmaps were generated using ComplexHeatmap software package⁵⁶ for statistical programming environment R. The R package arrayQualityMetric⁶⁷ was used for quality control and statistical testing of the arrays.

The microarray dataset has been deposited in the ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-6400 and will be released upon publication. Differentially expressed genes were determined with the limma package⁶⁸. Normalization of the arrays was done for both cell lines together using RMA, the additional normalization of array data was done with the BBmisc R package in the range −1, 1. The MetaCycle R package was used to determine the oscillating genes with the three built-in methods ARS, JTK and LS. The period was set to 21–27 h. Only genes with a Metacycle combined p-value lower than 0.05 were used for further analysis.

Enrichment analysis

The analysis in enriched pathways was performed using the KEGG data base. Enrichment analysis were performed in an open access online platform, DAVID Bioinformatics Resources 6.8⁵⁴ using the default settings.

ELISA

To detect the supernatant concentrations of TNF and IL-6, a “sandwich” enzyme-linked immunosorbent assay (ELISA) was performed using the Human TNF-α ELISA MAX™ Deluxe and Human IL-6 ELISA MAX™ Deluxe (Biolegend, San Diego, CA), respectively, according with the manufactorer’s instructions. Plates’ absorbance was read at 450 nm in VICTOR light 1420 (Perkin Elmer, Waltham, MA).

Cell cycle measurements

Cells used for cell cycle studies were washed with 1X PBS and fixed with ice-cold 80% ethanol. After fixation, cells were washed, resuspended in 150 µL of 1X PBS and stained for 30 min with 150 µL of a solution containing 0.05 mg/mL of PI (Sigma-Aldrich), 0.3% triton x-100 (Sigma-Aldrich) and 10 mg/mL of RNase (AppliChem GmbH, Darmstadt, Germany) in 1X PBS. Samples were read in FACSCabilur (Becton Dickinson, Franklin Lakes, NJ). The cells of interest were gated based on forward scatter/side scatter (FSC versus SSC) values. The cell cycle analysis was handled by fitting a univariate cell cycle model to the gated population using the Dean-Jett Fox⁶⁹ option, implemented in FlowJo v10.2 (FlowJo, LLC, Ashland, OR).

Proliferation, apoptosis, and migration measurements

Proliferation assays

For the proliferation assay, 2500 cells/well were seeded in a 96-well plate (Eppendorf). Cell were allowed to adhere and placed in the IncuCyte® S3 Live Cell System Analysis (Essen BioScience). Four pictures were recorded every hour for the 3 biological replicates and 4 technical replicates. Analysis were performed using the IncuCyte S3 Software (Essen BioScience).

Apoptosis assays

HD-MY-Z KD cell lines (shBmal1, shPer2, shRev-erbα and shTnf) as well as WT cells were seeded in 6-well plates containing RPMI 1640 (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco). At around 80% confluency cells were washed once with 1x PBS (Gibco) and counted using a Luna Automated Cell Counter. Cells were seeded in a 96-well plate (Eppendorf) at a concentration of 2500 cells/100 µL medium and incubated for 24 hours at 37 °C with 5% CO₂. For each cell line three biological replicates and four technical replicates were prepared. After 24 hours incubation, cell media were replaced with fresh medium containing caspase 3/7 (1:2000) and TNF (50 ng/mL) (only for the TNF stimulation experiment). Cell apoptosis was measured using the IncuCyte® S3 Live Cell System Analysis. Cells were scanned every 3 hours with a 10x objective and by using the phase and green image channels. Apoptosis data were normalized with the proliferation data for each cell line.

Migration assays

For the migration assay, 35000 cells/well were seeded in a 96-well Essen ImageLock^TM microplate (Essen BioScience) and incubated overnight at 37 °C, 5% CO₂. In the next day, the WoundMaker^TM (Essen BioScience) was used to create precise and reproducible wounds. The medium was replaced with fresh medium and the plate was placed in the IncuCyte® S3 Live Cell System Analysis (Essen BioScience). Image acquisition was performed by setting the “scan type” to Scratch Wound and Wide Mode, using the 10x objective. The plate was scanned every hour. Analysis was performed with the scratch wound method in the IncuCyte S3 Software (Essen BioScience).

Statistical Analysis

The experiments were carried out with at least three biological replicates for each condition. All results are represented as mean ± SEM. Statistical analysis was performed using two-tailed unpaired t-test. A p-value < 0.05 was considered as statistical significant. (*p < 0.05; **p < 0.01; ***p < 0.001).

Data availability

Data described in this study will be available from the corresponding author upon request. The microarray dataset has been deposited in the ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-6400.

References

Golombek, D. A. & Rosenstein, R. E. Physiology of circadian entrainment. Physiol Rev 90, 1063–1102, https://doi.org/10.1152/physrev.00009.2009 (2010).
Article PubMed CAS Google Scholar
Ralph, M. R., Foster, R. G., Davis, F. C. & Menaker, M. Transplanted suprachiasmatic nucleus determines circadian period. Science 247, 975–978 (1990).
Article ADS PubMed CAS Google Scholar
Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc Natl Acad Sci USA 111, 16219–16224, https://doi.org/10.1073/pnas.1408886111 (2014).
Article ADS PubMed CAS PubMed Central Google Scholar
Lehmann, R. et al. Assembly of a comprehensive regulatory network for the mammalian circadian clock: a bioinformatics approach. PLoS One 10, e0126283, https://doi.org/10.1371/journal.pone.0126283 (2015).
Article PubMed PubMed Central CAS Google Scholar
Relogio, A. et al. Tuning the mammalian circadian clock: robust synergy of two loops. PLoS Comput Biol 7, e1002309, https://doi.org/10.1371/journal.pcbi.1002309 (2011).
Article MathSciNet PubMed PubMed Central CAS Google Scholar
Sato, T. K. et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43, 527–537, https://doi.org/10.1016/j.neuron.2004.07.018 (2004).
Article PubMed CAS Google Scholar
Preitner, N. et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110, 251–260 (2002).
Article PubMed CAS Google Scholar
Relogio, A. et al. Ras-mediated deregulation of the circadian clock in cancer. PLoS Genet 10, e1004338, https://doi.org/10.1371/journal.pgen.1004338 (2014).
Article PubMed PubMed Central CAS Google Scholar
Padmanabhan, K., Robles, M. S., Westerling, T. & Weitz, C. J. Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. Science 337, 599–602, https://doi.org/10.1126/science.1221592 (2012).
Article ADS PubMed CAS Google Scholar
Kang, T. H., Reardon, J. T. & Sancar, A. Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein. Nucleic Acids Res 39, 3176–3187, https://doi.org/10.1093/nar/gkq1318 (2011).
Article PubMed CAS Google Scholar
Levi, F., Filipski, E., Iurisci, I., Li, X. M. & Innominato, P. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. Cold Spring Harb Symp Quant Biol 72, 465–475, https://doi.org/10.1101/sqb.2007.72.030 (2007).
Article PubMed CAS Google Scholar
Sahar, S. & Sassone-Corsi, P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer 9, 886–896, https://doi.org/10.1038/nrc2747 (2009).
Article PubMed CAS Google Scholar
Scheiermann, C., Kunisaki, Y. & Frenette, P. S. Circadian control of the immune system. Nat Rev Immunol 13, 190–198, https://doi.org/10.1038/nri3386 (2013).
Article PubMed PubMed Central CAS Google Scholar
El-Athman, R. et al. The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity. PLoS Biol 15, e2002940, https://doi.org/10.1371/journal.pbio.2002940 (2017).
Article PubMed PubMed Central CAS Google Scholar
Labrecque, N. & Cermakian, N. Circadian Clocks in the Immune System. J Biol Rhythms 30, 277–290, https://doi.org/10.1177/0748730415577723 (2015).
Article PubMed CAS Google Scholar
Smaaland, R., Lote, K., Sothern, R. B. & Laerum, O. D. DNA synthesis and ploidy in non-Hodgkin’s lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling. Cancer Res 53, 3129–3138 (1993).
PubMed CAS Google Scholar
Rich, T. et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 11, 1757–1764, https://doi.org/10.1158/1078-0432.CCR-04-2000 (2005).
Article PubMed CAS Google Scholar
Nakao, A. Temporal regulation of cytokines by the circadian clock. J Immunol Res 2014, 614529, https://doi.org/10.1155/2014/614529 (2014).
Article PubMed PubMed Central CAS Google Scholar
Dumbell, R., Matveeva, O. & Oster, H. Circadian Clocks, Stress, and Immunity. Front Endocrinol (Lausanne) 7, 37, https://doi.org/10.3389/fendo.2016.00037 (2016).
Article Google Scholar
Early, J. O. & Curtis, A. M. Immunometabolism: Is it under the eye of the clock? Semin Immunol 28, 478–490, https://doi.org/10.1016/j.smim.2016.10.006 (2016).
Article PubMed CAS Google Scholar
Geiger, S. S., Fagundes, C. T. & Siegel, R. M. Chrono-immunology: progress and challenges in understanding links between the circadian and immune systems. Immunology 146, 349–358, https://doi.org/10.1111/imm.12525 (2015).
Article PubMed PubMed Central CAS Google Scholar
Wegrzyn, L. R. et al. Rotating Night-Shift Work and the Risk of Breast Cancer in the Nurses’ Health Studies. Am J Epidemiol 186, 532–540, https://doi.org/10.1093/aje/kwx140 (2017).
Article PubMed PubMed Central Google Scholar
Devore, E. E. et al. Rotating night shift work, sleep, and colorectal adenoma in women. Int J Colorectal Dis 32, 1013–1018, https://doi.org/10.1007/s00384-017-2758-z (2017).
Article PubMed PubMed Central Google Scholar
Heckman, C. J., Kloss, J. D., Feskanich, D., Culnan, E. & Schernhammer, E. S. Associations among rotating night shift work, sleep and skin cancer in Nurses’ Health Study II participants. Occup Environ Med 74, 169–175, https://doi.org/10.1136/oemed-2016-103783 (2017).
Article PubMed Google Scholar
Reszka, E. et al. Circadian gene expression in peripheral blood leukocytes of rotating night shift nurses. Scand J Work Environ Health 39, 187–194, https://doi.org/10.5271/sjweh.3303 (2013).
Article PubMed CAS Google Scholar
Lahti, T. A., Partonen, T., Kyyronen, P., Kauppinen, T. & Pukkala, E. Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer 123, 2148–2151, https://doi.org/10.1002/ijc.23566 (2008).
Article PubMed CAS Google Scholar
Calafat, J. et al. Human monocytes and neutrophils store transforming growth factor-alpha in a subpopulation of cytoplasmic granules. Blood 90, 1255–1266 (1997).
PubMed CAS Google Scholar
Kramer, A. et al. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalling. Novartis Found Symp 253, 250–262; discussion 102-259, 263-256, 281-254 (2003).
Bornstein, S. R. et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83, 280–283, https://doi.org/10.1210/jcem.83.1.4610 (1998).
Article PubMed CAS Google Scholar
Keller, M. et al. A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci USA 106, 21407–21412, https://doi.org/10.1073/pnas.0906361106 (2009).
Article ADS PubMed CAS PubMed Central Google Scholar
Suzuki, T. et al. Period is involved in the proliferation of human pancreatic MIA-PaCa2 cancer cells by TNF-alpha. Biomed Res 29, 99–103 (2008).
Article PubMed CAS Google Scholar
Logan, R. W. & Sarkar, D. K. Circadian nature of immune function. Mol Cell Endocrinol 349, 82–90, https://doi.org/10.1016/j.mce.2011.06.039 (2012).
Article PubMed CAS Google Scholar
Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607, https://doi.org/10.1038/nature11003 (2012).
Article ADS PubMed PubMed Central CAS Google Scholar
Lister, T. A. et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7, 1630–1636, https://doi.org/10.1200/JCO.1989.7.11.1630 (1989).
Article PubMed CAS Google Scholar
Yoshida, K. et al. TNF-alpha induces expression of the circadian clock gene Bmal1 via dual calcium-dependent pathways in rheumatoid synovial cells. Biochem Biophys Res Commun 495, 1675–1680, https://doi.org/10.1016/j.bbrc.2017.12.015 (2018).
Article PubMed CAS Google Scholar
Yoshida, K. et al. TNF-alpha modulates expression of the circadian clock gene Per2 in rheumatoid synovial cells. Scand J Rheumatol 42, 276–280, https://doi.org/10.3109/03009742.2013.765031 (2013).
Article PubMed CAS Google Scholar
Li, P., Zheng, Y. & Chen, X. Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics. Front Pharmacol 8, 460, https://doi.org/10.3389/fphar.2017.00460 (2017).
Article PubMed PubMed Central CAS Google Scholar
Kiessling, S. et al. Enhancing circadian clock function in cancer cells inhibits tumor growth. BMC Biol 15, 13, https://doi.org/10.1186/s12915-017-0349-7 (2017).
Article PubMed PubMed Central CAS Google Scholar
Dahle, M. K., Myhre, A. E., Aasen, A. O. & Wang, J. E. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9. Infect Immun 73, 7290–7296, https://doi.org/10.1128/IAI.73.11.7290-7296.2005 (2005).
Article PubMed PubMed Central CAS Google Scholar
Vener, C. et al. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin’s disease at diagnosis. Leuk Lymphoma 37, 333–339, https://doi.org/10.3109/10428190009089433 (2000).
Article PubMed CAS Google Scholar
McDevitt, H., Munson, S., Ettinger, R. & Wu, A. Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity. Arthritis Res 4(Suppl 3), S141–152, https://doi.org/10.1186/ar570 (2002).
Article PubMed PubMed Central Google Scholar
Curtis, A. M., Bellet, M. M., Sassone-Corsi, P. & O’Neill, L. A. Circadian clock proteins and immunity. Immunity 40, 178–186, https://doi.org/10.1016/j.immuni.2014.02.002 (2014).
Article PubMed CAS Google Scholar
Ebong, S. J. et al. Immunopathologic responses to non-lethal sepsis. Shock 12, 118–126 (1999).
Article PubMed CAS Google Scholar
Leone, M. J., Marpegan, L., Duhart, J. M. & Golombek, D. A. Role of proinflammatory cytokines on lipopolysaccharide-induced phase shifts in locomotor activity circadian rhythm. Chronobiol Int 29, 715–723, https://doi.org/10.3109/07420528.2012.682681 (2012).
Article PubMed CAS Google Scholar
Arjona, A. & Sarkar, D. K. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J Immunol 174, 7618–7624 (2005).
Article PubMed CAS Google Scholar
Reynolds, G. M. et al. Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of ‘B’ symptoms and failure to achieve complete remission in patients with advanced Hodgkin’s disease. Br J Haematol 118, 195–201 (2002).
Article PubMed CAS Google Scholar
Maggio, E. et al. Chemokines, cytokines and their receptors in Hodgkin’s lymphoma cell lines and tissues. Ann Oncol 13(Suppl 1), 52–56 (2002).
Article PubMed Google Scholar
Petrzilka, S., Taraborrelli, C., Cavadini, G., Fontana, A. & Birchler, T. Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling. J Biol Rhythms 24, 283–294, https://doi.org/10.1177/0748730409336579 (2009).
Article PubMed CAS Google Scholar
Cavadini, G. et al. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 104, 12843–12848, https://doi.org/10.1073/pnas.0701466104 (2007).
Article ADS PubMed PubMed Central Google Scholar
El-Athman, R. & Relogio, A. Escaping Circadian Regulation: An Emerging Hallmark of Cancer? Cell Syst 6, 266–267, https://doi.org/10.1016/j.cels.2018.03.006 (2018).
Article PubMed CAS Google Scholar
Fu, L. & Lee, C. C. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3, 350–361, https://doi.org/10.1038/nrc1072 (2003).
Article PubMed CAS Google Scholar
Puram, R. V. et al. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell 165, 303–316, https://doi.org/10.1016/j.cell.2016.03.015 (2016).
Article PubMed PubMed Central CAS Google Scholar
Kiessling, S. & Cermakian, N. The tumor circadian clock: a new target for cancer therapy? Future Oncol 13, 2607–2610, https://doi.org/10.2217/fon-2017-0456 (2017).
Article PubMed CAS Google Scholar
Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44–57, https://doi.org/10.1038/nprot.2008.211 (2009).
Article PubMed CAS Google Scholar
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498–2504, https://doi.org/10.1101/gr.1239303 (2003).
Article PubMed PubMed Central CAS Google Scholar
Zuguang, G. ComplexHeatmap: Making Complex Heatmaps. R package version 1.6.0., https://github.com/jokergoo/ComplexHeatmap (2015).
Fehrhart, M. K. Circadian rythm related genes (Homo sapiens), https://www.wikipathways.org/index.php/Pathway:WP3594 (2015).
Basic, V. T., Jacobsen, A., Sirsjo, A. & Abdel-Halim, S. M. TNF stimulation induces VHL overexpression and impairs angiogenic potential in skeletal muscle myocytes. Int J Mol Med 34, 228–236, https://doi.org/10.3892/ijmm.2014.1776 (2014).
Article PubMed CAS Google Scholar
Correa, F., Mallard, C., Nilsson, M. & Sandberg, M. Dual TNFalpha-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: role of protein kinase activation. Neurochem Res 37, 2842–2855, https://doi.org/10.1007/s11064-012-0878-y (2012).
Article PubMed PubMed Central CAS Google Scholar
Gutzkow, K. B., Naderi, S. & Blomhoff, H. K. Forskolin-mediated G1 arrest in acute lymphoblastic leukaemia cells: phosphorylated pRB sequesters E2Fs. J Cell Sci 115, 1073–1082 (2002).
PubMed CAS Google Scholar
Shayo, C. et al. The time-course of cyclic AMP signaling is critical for leukemia U-937 cell differentiation. Biochem Biophys Res Commun 314, 798–804 (2004).
Article PubMed CAS Google Scholar
Ben-Ari, J. et al. Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasone. Clin Diagn Lab Immunol 7, 553–556 (2000).
PubMed PubMed Central CAS Google Scholar
Nakayama, S. et al. Expression of tumour necrosis factor-alpha and its receptors in Hodgkin lymphoma. Br J Haematol 167, 574–577, https://doi.org/10.1111/bjh.13015 (2014).
Article PubMed CAS Google Scholar
Warzocha, K. et al. Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin’s disease patients. Br J Cancer 77, 2357–2362 (1998).
Article PubMed PubMed Central CAS Google Scholar
Sporl, F. et al. A circadian clock in HaCaT keratinocytes. J Invest Dermatol 131, 338–348, https://doi.org/10.1038/jid.2010.315 (2011).
Article PubMed CAS Google Scholar
Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264, https://doi.org/10.1093/biostatistics/4.2.249 (2003).
Article PubMed MATH Google Scholar
Kauffmann, A., Gentleman, R. & Huber, W. arrayQualityMetrics–a bioconductor package for quality assessment of microarray data. Bioinformatics 25, 415–416, https://doi.org/10.1093/bioinformatics/btn647 (2009).
Article PubMed CAS Google Scholar
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47, https://doi.org/10.1093/nar/gkv007 (2015).
Article PubMed PubMed Central CAS Google Scholar
Dean, P. N. & Jett, J. H. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 60, 523–527 (1974).
Article PubMed PubMed Central CAS Google Scholar

Download references

Acknowledgements

We thank Ute Ungethüm from the LFGC (Labor für funktionelle Genomforschung, Charité - Universitätsmedizin Berlin) for technical support regarding the microarrays work. Work in AR’s laboratory is supported by the German Federal Ministry of Education and Research (BMBF)—eBio-CIRSPLICE - FKZ031A316 and by the Dr. Rolf M. Schwiete Stiftung. NG was additionally funded by the Berlin School of Integrative Oncology (BSIO) of the Charité – Universitätsmedizin Berlin. Work in GM’s laboratory was funded by the “5 × 1000” voluntary contribution and by a grant from the Italian Ministry of Health(RC1603ME43, RC1703ME43 and RC1803ME40).

Author information

Authors and Affiliations

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Institute for Theoretical Biology, Berlin, Germany
Mónica Abreu, Alireza Basti, Nikolai Genov & Angela Relógio
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt - Universität zu Berlin, and Berlin Institute of Health, Medical Department of Hematology, Oncology, and Tumor Immunology, Molecular Cancer Research Center, Berlin, Germany
Mónica Abreu, Alireza Basti, Nikolai Genov & Angela Relógio
Department of Medical Sciences, Division of Internal Medicine and Chronobiology Unit, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG), Italy
Gianluigi Mazzoccoli

Authors

Mónica Abreu
View author publications
You can also search for this author in PubMed Google Scholar
Alireza Basti
View author publications
You can also search for this author in PubMed Google Scholar
Nikolai Genov
View author publications
You can also search for this author in PubMed Google Scholar
Gianluigi Mazzoccoli
View author publications
You can also search for this author in PubMed Google Scholar
Angela Relógio
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

Conceived and designed the work: A.R. Performed the wet lab experiments: M.A., A.B. Performed the bioinformatics analysis: M.A., N.G. Analysed the data: M.A., A.B., N.G., G.M., A.R. Contributed reagents/materials/analysis tools: A.R. Wrote the paper: M.A., A.B., G.M., A.R. critically read and commented on the paper: M.A., A.B., N.G., G.M., A.R.

Corresponding author

Correspondence to Angela Relógio.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Supplementary Information

Supplementary Table 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Abreu, M., Basti, A., Genov, N. et al. The reciprocal interplay between TNFα and the circadian clock impacts on cell proliferation and migration in Hodgkin lymphoma cells. Sci Rep 8, 11474 (2018). https://doi.org/10.1038/s41598-018-29847-z

Download citation

Received: 26 March 2018
Accepted: 18 July 2018
Published: 31 July 2018
DOI: https://doi.org/10.1038/s41598-018-29847-z

This article is cited by

The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia
- Emanuele Murgo
- Elisabetta De Santis
- Vincenzo Giambra
Journal of Experimental & Clinical Cancer Research (2023)
A bioinformatic analysis identifies circadian expression of splicing factors and time-dependent alternative splicing events in the HD-MY-Z cell line
- Nikolai Genov
- Alireza Basti
- Angela Relógio
Scientific Reports (2019)
Cancer and cancer survival modulates brain and behavior in a time-of-day-dependent manner in mice
- Jessica C. Santos
- Savannah R. Bever
- Leah M. Pyter
Scientific Reports (2019)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.